Nusano
West Valley City, US · 6 known investors
Nusano produces medical radioisotopes for use in theranostic compounds and cancer treatment applications. The company serves the healthcare and oncology sectors by making radioisotopes available for targeted radiopharmaceutical therapies.
Founders & leadership
Investors · 6
Also in the syndicate · 3
BrightEdgeThe Wasatch GroupleadVerily
Funding
SEC filings, press & company announcements$115M disclosed across 1 of 2 rounds · 2023–2024
- $115MSeries COct 2024 · 2 sources
The Wasatch Group (lead), BrightEdge, S32, Verily
Source ↗ - Undisclosed amountseed funding roundJan 2023Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Nusano do?
- Nusano produces medical radioisotopes for use in theranostic compounds and cancer treatment applications. The company serves the healthcare and oncology sectors by making radioisotopes available for targeted radiopharmaceutical therapies.
- Who founded Nusano?
- Nusano was founded by Howard C. Lewin, Glenn B. Rosenthal.
- Who are Nusano's investors?
- Nusano's investors include Wasatch Equity Partners, Section 32, S32.
- How much funding has Nusano raised?
- Nusano has disclosed $115M raised across 1 of its 2 known rounds.
- Where is Nusano headquartered?
- Nusano is headquartered in West Valley City, US.


